The agenda that will shape pharma's future

Full Agenda

Keynote
09:00 – 09:30
We all work in patient engagement now. Let’s make it work.
  • Convert the laggard critics with a narrative and evidence that justifies your patient-first approach, regardless of function
  • No more check-boxes: build a structure where patient engagement is a non-discretionary, genuine constant through every stage of development
09:00 – 09:30
Panel: Why your company’s patient commitment starts in the boardroom
  • Culture eats strategy: how to support leadership in making the case for patient centricity through proven success and identifiable change
  • How to find and support champions across your company
09:00 – 09:30
Case Study: From a blank canvas, see how Genentech were able to build a new patient engagement function from the ground up
  • Second-mover advantage: see how Genentech built the frameworks, using best practice, that enabled a fresh approach to engagement
  • Understand why Genentech now believes 80% of each project design should come from the patient voice – and how to figure out the other 20%!
09:00 – 09:30
Case Study: Partner with patient innovators to incubate a new generation of patient entrepreneurs
  • Give patients the platform and tools to become problem solvers for their own disease areas by becoming the innovators
  • Create patient value by supporting patient efforts to innovate in disease care
09:00 – 09:30
An essential briefing on the FDA's work to advance the patient voice as a contributor to key decisions
  • The latest: get an update directly from FDA staff responsible for engagement
  • How patient advocates can actively engage with the FDA
  • Why Patient-Reported Outcomes are becoming more integral to FDA decision making
09:00 – 09:30
Case Study: How pharma companies can learn from the Cleveland Clinic’s experiences in co-creating services with patients
  • Why Cleveland Clinic are elevating the patient voice to design health services
  • Create best-in-class processes for engaging and co-designing with patients
  • Case Study: Translate patient-led design into tangible changes in healthcare delivery
09:00 – 09:30
How pharma companies can help solve and elucidate the Anti-Vaxx Fake News crisis
  • Understand that the new health (dis)information age requires a pro-active management strategy from pharma – in vaccines and beyond
  • How do you prove the truth? Understand the extent to which “fake news” is causing problems for the healthcare system and what we can do about it
  • Deliver the correct information to patients in a compliant yet digestible format and style in order to get your message across
Join the industry’s innovators, register now to save $200
Digital Patient Solutions
09:00 – 09:30
Case Study: How Takeda and MIT innovated the engagement paradigm to ensure greater insights and understanding in paediatric care
  • Witness Takeda and MIT Media Lab’s reimagination of PRO collection with children in pediatric care
  • Gamification isn’t dead: tailor your engagement methods to quicken patient progression in appropriate audience segments
  • Sharing is caring: why Takeda are making their core IP open-source, once it has received FDA Approval
09:00 – 09:30
Panel: Is Digital the approach or the answer?
  • Start with the patient: how a patient-first approach has ensured Otsuka’s solutions are driven with purpose, not technology
  • Mix the key ingredients to a successful digital platform that your patients can use and understand
  • Best-practice guidelines on avoiding low take-up of digital solutions by patients
09:00 – 09:30
Case Study: How digital is disrupting our capacity for patient engagement
  • Why real-time patient data is the answer to understanding the life of your patient at the deepest level
  • Use digital techniques to improve healthcare decisions by giving patients ownership over their own health data
09:00 – 09:30
Case Study: Why Ipsen turned to digital methods in initiatives to improve adherence
  • See why the key to Ipsen’s success was to fit their product around the daily lives of their patients
  • Learn from other industries on how they engage with their customers at every point of the product journey to improve adherence
Optimize Patient Partnerships
09:00 – 09:30
Case Study: How the mutual benefits of active listening created a new dynamic for AstraZeneca and it’s patients
  • How listening and understanding to the patient enhanced AstraZeneca’s ability to help it’s patients
  • Why active listening allows for a mutually beneficial partnership between the patient and the pharma company
09:00 – 09:30
Panel: Why a holistic patient experience cannot exist without a holistic approach to working within your walls
  • Remove the “that’s not my department” mentality from your company’s engagement to spur more meaningful initiatives
  • If you don’t know how each function works with patients, how can the patient? across different functions for a seamless patient experience
09:00 – 09:30
Panel: Should the ‘Why’ be the ROI? Focus on patient value, knowing that will bring your company ROI in the long-term
  • Understand why seeking direct ROI for patient engagement can hinder your performance in gaining insights
  • Examine whether your company should transition to a model that doesn’t focus on ROI as proof of success in patient relations
  • How to wisen patients to their own healthcare options to show clinical trials as a viable treatment option
09:00 – 09:30
Compliance as your cheerleader: How to innovate without being killed by legal
  • Build a compliant governance structure that can keep pace with project needs across function teams, even as they innovate
  • Case Study: How Sanofi have built a framework that allows for oversight without stifling innovation
  • Create an organization-wide pipeline to coordinate patient data more effectively
09:00 – 09:30
Case Study: How one pharma company has connected hundreds of patient groups around the world
  • Dive into a global advocacy initiative to connect similar advocacy groups with each other, enable learning, foster collaboration and driving economies of scale
  • Assist advocacy groups to build their own network so they can become the best partners in healthcare possible
09:00 – 09:30
Panel: Understand pharma’s role in upskilling advocacy groups to improve patient value
  • Case Study: how you can support patient groups with the knowledge needed to become a more effective organization
  • How listening to patient group needs is essential to providing the right kind of support
  • Support your advocacy partners in the most transparent way by using an open process to ask and give assistance
Join the industry’s innovators, register now to save $200
Patient-Centered Trial Design as a Minimum Standard
09:00 – 09:30
Panel: Better trial design through pro-active patient collaboration
  • How to ensure enrolment and retention rates are boosted by specific efforts when involving patients in the design and development of trials
  • Case study: See how Janssen’s proactive engagement helped avoid many problems that occur as trial development advanced
09:00 – 09:30
Case Study: Examine how Janssen’s Global Trial Community is able to provide a holistic experience for patients
  • See Janssen’s new Alumni program that keeps patients engaged in their trial community through interactive patient data return
  • Learn from your patient too: why this new apparatus has improved Janssen’s knowledge about their protocol design
09:00 – 09:30
How patient groups are developing their own registries, and we can all benefit
  • Learn why patient groups are developing their own data sources and how your company can work with them
  • Ways to reduce the burden on RCTs through access to patient registry data
Make Patient-Focused Drug Development a Reality
09:00 – 09:30
Rethink early stage research with stronger patient insights
  • A guide to partnering with patients with the intention of discover new research opportunities
  • How to structure patient engagement to ensure you fully understand unmet need
  • Understand how best to translate insights into clinical strategy
09:00 – 09:30
Case Study: How Janssen is ensuring its trials are representative of its patient populations
  • Why Janssen has prioritized efforts which is improve diversity of the company’s clinical trials
  • Treat the cause, not the symptoms: understand the true reasons why your patient populations are underrepresented as a key step in improving your trial diversity
09:00 – 09:30
Case Study: Engage with social media to upscale your Clinical Trial Recruitment
  • Engage your patient population in the place they receive their information, to increase trial enrolment
  • Remove the stigma and clinical trials by presenting your information in a digestible and accessible format
09:00 – 09:30
Case Study: Pfizer’s new commitment to being bilingual in patient-speak and industry-speak in everything it says
  • Dive into Pfizer’s new processes for translating the data it disseminates into patient-friendly language to avoid being lost in translation
  • Build trust in your organization by extending transparency: inform patients of what you’re doing at every turn
09:00 – 09:30
Health Literacy: The Elephant in the Room
  • Case Study: How Merck have improved Health Literacy rates and other benefits by addressing the issue pro-actively
  • Medicine is not enough: why health literacy is a vital way to improving outcomes for treatments already on the market

Keynotes

Keynote
09:00 – 09:30
We all work in patient engagement now. Let’s make it work.
  • Convert the laggard critics with a narrative and evidence that justifies your patient-first approach, regardless of function
  • No more check-boxes: build a structure where patient engagement is a non-discretionary, genuine constant through every stage of development
09:00 – 09:30
Panel: Why your company’s patient commitment starts in the boardroom
  • Culture eats strategy: how to support leadership in making the case for patient centricity through proven success and identifiable change
  • How to find and support champions across your company
09:00 – 09:30
Case Study: From a blank canvas, see how Genentech were able to build a new patient engagement function from the ground up
  • Second-mover advantage: see how Genentech built the frameworks, using best practice, that enabled a fresh approach to engagement
  • Understand why Genentech now believes 80% of each project design should come from the patient voice – and how to figure out the other 20%!
09:00 – 09:30
Case Study: Partner with patient innovators to incubate a new generation of patient entrepreneurs
  • Give patients the platform and tools to become problem solvers for their own disease areas by becoming the innovators
  • Create patient value by supporting patient efforts to innovate in disease care
09:00 – 09:30
An essential briefing on the FDA's work to advance the patient voice as a contributor to key decisions
  • The latest: get an update directly from FDA staff responsible for engagement
  • How patient advocates can actively engage with the FDA
  • Why Patient-Reported Outcomes are becoming more integral to FDA decision making
09:00 – 09:30
Case Study: How pharma companies can learn from the Cleveland Clinic’s experiences in co-creating services with patients
  • Why Cleveland Clinic are elevating the patient voice to design health services
  • Create best-in-class processes for engaging and co-designing with patients
  • Case Study: Translate patient-led design into tangible changes in healthcare delivery
09:00 – 09:30
How pharma companies can help solve and elucidate the Anti-Vaxx Fake News crisis
  • Understand that the new health (dis)information age requires a pro-active management strategy from pharma – in vaccines and beyond
  • How do you prove the truth? Understand the extent to which “fake news” is causing problems for the healthcare system and what we can do about it
  • Deliver the correct information to patients in a compliant yet digestible format and style in order to get your message across

Commercial

Digital Patient Solutions
09:00 – 09:30
Case Study: How Takeda and MIT innovated the engagement paradigm to ensure greater insights and understanding in paediatric care
  • Witness Takeda and MIT Media Lab’s reimagination of PRO collection with children in pediatric care
  • Gamification isn’t dead: tailor your engagement methods to quicken patient progression in appropriate audience segments
  • Sharing is caring: why Takeda are making their core IP open-source, once it has received FDA Approval
09:00 – 09:30
Panel: Is Digital the approach or the answer?
  • Start with the patient: how a patient-first approach has ensured Otsuka’s solutions are driven with purpose, not technology
  • Mix the key ingredients to a successful digital platform that your patients can use and understand
  • Best-practice guidelines on avoiding low take-up of digital solutions by patients
09:00 – 09:30
Case Study: How digital is disrupting our capacity for patient engagement
  • Why real-time patient data is the answer to understanding the life of your patient at the deepest level
  • Use digital techniques to improve healthcare decisions by giving patients ownership over their own health data
09:00 – 09:30
Case Study: Why Ipsen turned to digital methods in initiatives to improve adherence
  • See why the key to Ipsen’s success was to fit their product around the daily lives of their patients
  • Learn from other industries on how they engage with their customers at every point of the product journey to improve adherence
Optimize Patient Partnerships
09:00 – 09:30
Case Study: How the mutual benefits of active listening created a new dynamic for AstraZeneca and it’s patients
  • How listening and understanding to the patient enhanced AstraZeneca’s ability to help it’s patients
  • Why active listening allows for a mutually beneficial partnership between the patient and the pharma company
09:00 – 09:30
Panel: Why a holistic patient experience cannot exist without a holistic approach to working within your walls
  • Remove the “that’s not my department” mentality from your company’s engagement to spur more meaningful initiatives
  • If you don’t know how each function works with patients, how can the patient? across different functions for a seamless patient experience
09:00 – 09:30
Panel: Should the ‘Why’ be the ROI? Focus on patient value, knowing that will bring your company ROI in the long-term
  • Understand why seeking direct ROI for patient engagement can hinder your performance in gaining insights
  • Examine whether your company should transition to a model that doesn’t focus on ROI as proof of success in patient relations
  • How to wisen patients to their own healthcare options to show clinical trials as a viable treatment option
09:00 – 09:30
Compliance as your cheerleader: How to innovate without being killed by legal
  • Build a compliant governance structure that can keep pace with project needs across function teams, even as they innovate
  • Case Study: How Sanofi have built a framework that allows for oversight without stifling innovation
  • Create an organization-wide pipeline to coordinate patient data more effectively
09:00 – 09:30
Case Study: How one pharma company has connected hundreds of patient groups around the world
  • Dive into a global advocacy initiative to connect similar advocacy groups with each other, enable learning, foster collaboration and driving economies of scale
  • Assist advocacy groups to build their own network so they can become the best partners in healthcare possible
09:00 – 09:30
Panel: Understand pharma’s role in upskilling advocacy groups to improve patient value
  • Case Study: how you can support patient groups with the knowledge needed to become a more effective organization
  • How listening to patient group needs is essential to providing the right kind of support
  • Support your advocacy partners in the most transparent way by using an open process to ask and give assistance

Clinical

Patient-Centered Trial Design as a Minimum Standard
09:00 – 09:30
Panel: Better trial design through pro-active patient collaboration
  • How to ensure enrolment and retention rates are boosted by specific efforts when involving patients in the design and development of trials
  • Case study: See how Janssen’s proactive engagement helped avoid many problems that occur as trial development advanced
09:00 – 09:30
Case Study: Examine how Janssen’s Global Trial Community is able to provide a holistic experience for patients
  • See Janssen’s new Alumni program that keeps patients engaged in their trial community through interactive patient data return
  • Learn from your patient too: why this new apparatus has improved Janssen’s knowledge about their protocol design
09:00 – 09:30
How patient groups are developing their own registries, and we can all benefit
  • Learn why patient groups are developing their own data sources and how your company can work with them
  • Ways to reduce the burden on RCTs through access to patient registry data
Make Patient-Focused Drug Development a Reality
09:00 – 09:30
Rethink early stage research with stronger patient insights
  • A guide to partnering with patients with the intention of discover new research opportunities
  • How to structure patient engagement to ensure you fully understand unmet need
  • Understand how best to translate insights into clinical strategy
09:00 – 09:30
Case Study: How Janssen is ensuring its trials are representative of its patient populations
  • Why Janssen has prioritized efforts which is improve diversity of the company’s clinical trials
  • Treat the cause, not the symptoms: understand the true reasons why your patient populations are underrepresented as a key step in improving your trial diversity
09:00 – 09:30
Case Study: Engage with social media to upscale your Clinical Trial Recruitment
  • Engage your patient population in the place they receive their information, to increase trial enrolment
  • Remove the stigma and clinical trials by presenting your information in a digestible and accessible format
09:00 – 09:30
Case Study: Pfizer’s new commitment to being bilingual in patient-speak and industry-speak in everything it says
  • Dive into Pfizer’s new processes for translating the data it disseminates into patient-friendly language to avoid being lost in translation
  • Build trust in your organization by extending transparency: inform patients of what you’re doing at every turn
09:00 – 09:30
Health Literacy: The Elephant in the Room
  • Case Study: How Merck have improved Health Literacy rates and other benefits by addressing the issue pro-actively
  • Medicine is not enough: why health literacy is a vital way to improving outcomes for treatments already on the market

Don’t pay lip-service to patient centricity.
Make it happen.